Abstract
Toxic epidermal necrolysis (TEN) is an acute, severe, often life-threatening skin reaction, which is characterized by extensive necrosis and detachment of the epidermis and mucous membranes. It has been observed worldwide and affects people of both sexes and all ages. It occurs more often in the elderly and women and its incidence is about 0.4–1.3 cases per million per year.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Further reading
Arevalo JM, Lorente JA. Skin coverage with Biobrane biomaterial for the treatment of patients with toxic epidermal necrolysis. J Burn Care Rehabil 1999; 20: 406–10.
Chaidemenos G, Chrysomallis F, Sombolos K et al Plasmapheresis in toxic epidermal necrolysis. IntJDermatol 1997; 36: 218–21.
Egan CA, Grant WJ, Morris SE, Saffle JR, Zone JJ. Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis. J Am Acad Dermatol 1999; 40: 458–61.
Furubacke A, Berlin G, Anderson C, Sjoberg F. Lack of significant treatment effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis? Intensive Care Med 1999; 25: 1307–10.
Green D, Law E, Still JM. An approach to the management of toxic epidermal necrolysis in a burn centre. Burns 1997; 19 (5): 411–14.
Guibal F, Bastuji-Garin S, Chosidow O et al Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy. Arch Dermatol 1995; 131: 669–72.
Heng MCY, Allen SG. Efficacy of cyclophosphamide in toxic epidermal necrolysis. J Am Acad Dermato11991; 25: 778–86.
Ioannides D, Vakali G, Chrysomallis F et al Toxic epidermal necrolysis: a study of 22 cases. JEADV 1994; 3: 266–75.
Kelemen JJ III, Cioffi WG, McManus WF et al Burn center care for patients with toxic epidermal necrolysis. JAm Coll Surg 1995; 180 (3): 273–8.
Magina S, Lisboa C, Goncalves E et al. A case of toxic epidermal necrolysis treated with intravenous immunoglobin.Br J Dermatol 2000; 142: 191–2.
Paquet P, Pierard GE. Would cyclosporin A be beneficial to mitigate drug-induced toxic epidermal necrolysis? Dermatology 1999; 198: 198–202.
Renfro L, Grant-Krels JM, Daman LA. Drug-induced toxic epidermal necrolysis treated with cyclosporin. Int J Dermatol 1989; 28: 441–4.
Roujeau JC. Treatment of severe drug eruptions. J Dermatol 1999; 26: 718–22.
Roujeau J-C, Chosidow O, Saiag P, Guillaume J-C. Toxic epidermal necrolysis (Lyell syndrome). JAm Acad Dermatol 1990; 23: 1039–58.
Yamada H, Takamori K, Yaguchi H, Ogawa H. A study of the efficacy of plasmapheresis for the treatment of drug induced toxic epidermal necrolysis. Ther Apher 1998; 2: 153–6.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Minas, A. (2003). Toxic epidermal necrolysis (Lyell’s syndrome). In: Katsambas, A.D., Lotti, T.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07131-1_96
Download citation
DOI: https://doi.org/10.1007/978-3-662-07131-1_96
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-05657-4
Online ISBN: 978-3-662-07131-1
eBook Packages: Springer Book Archive